Quest Stock To Go Ex-dividend Tomorrow (DGX)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- The ex-dividend date for Quest Diagnostics (NYSE: DGX) is tomorrow, January 9, 2013. Owners of shares as of market close today will be eligible for a dividend of 30 cents per share. At a price of $57.86 as of 9:31 a.m. ET, the dividend yield is 2.1%.

The average volume for Quest has been 877,300 shares per day over the past 30 days. Quest has a market cap of $9.22 billion and is part of the health care sector and health services industry. Shares are down 0.5% year to date as of the close of trading on Monday.

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company has a P/E ratio of 13.5, below the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Quest as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Quest Ratings Report.

See our dividend calendar or top-yielding stocks list.

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.
null

If you liked this article you might like

Cramer: These Sectors Look Bullish (Part III)

Cramer: There Are Powerful Themes in Several Bull Markets

Stanley Black & Decker, Quest Diagnostics and 2 More Could Rocket Higher This Spring -- Here's Why

MasterCard, Intuitive Surgical and 2 More Could Rocket Higher This Spring--Here's Why …

Market Recon: If You Are Scared, Don't Show It